Abstract
In this study, the effect of dexamethasone on the formation of pneumococcal antibodies during community-acquired pneumonia (CAP) was investigated. No differences between CAP patients receiving dexamethasone as additional therapy and patients receiving a placebo were found with respect to immune response rates and mean baseline and convalescent-phase antibody concentrations. Copyright © 2012, American Society for Microbiology.
Cite
CITATION STYLE
Van Mens, S. P., Meijvis, S. C. A., Grutters, J. C., Vlaminckx, B. J. M., Bos, W. J. W., & Rijkers, G. T. (2012). Dexamethasone treatment has no effect on the formation of pneumococcal antibodies during community-acquired pneumonia. Clinical and Vaccine Immunology, 19(5), 811–813. https://doi.org/10.1128/CVI.05697-11
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.